Education
About Us
Working with TipRanks
Follow Us
Teladoc (TDOC)
NYSE:TDOC
TDOC Stock Chart & Stats
$8.53
-$0.30(-3.00%)
At close: 4:00 PM EST
$8.53
-$0.30(-3.00%)
Day’s Range― - ―
52-Week Range$6.35 - $15.21
Previous CloseN/A
Volume1.13M
Average Volume (3M)7.50M
Market Cap
$1.51B
Enterprise Value$1.89B
Total Cash (Recent Filing)$679.62M
Total Debt (Recent Filing)$1.03B
Price to Earnings (P/E)―
Beta1.40
Next Earnings
Oct 29, 2025EPS Estimate
-0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding176,690,660
10 Day Avg. Volume9,412,163
30 Day Avg. Volume7,501,967
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.04
Price to Sales (P/S)0.60
P/FCF Ratio5.48
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue0.74
Enterprise Value/Gross Profit1.06
Enterprise Value/Ebitda35.19
Forecast
1Y Price Target
$8.94Price Target Upside4.81% Upside
Rating ConsensusHold
Number of Analyst Covering12
Bulls Say, Bears Say
Bulls Say
Catapult Acquisition PerformanceThe Catapult acquisition is performing slightly ahead of plan and is expected to be a 200bps tailwind to IC revenue in 2025.
Expansion Of Insurance CapabilitiesTeladoc is making progress by adding insurance capabilities through UpLift, with a soft launch in a single state and recent contract wins to add over 15 million lives.
Growth In Livongo MAUsLivongo MAUs grew 55% year over year in August, showing a significant acceleration from the declines over the last 15 months.
Bears Say
Challenges In Cash Pay BusinessThe cash pay business continues to struggle with high acquisition costs and churn, reinforcing TDOC’s strategic shift to an insurance-based model.
Decline In BetterHelp MAUsGlobal BetterHelp MAUs declined 9% year over year, with a 7% decline in the U.S. and an 18% decline internationally, marking the fifth consecutive month of year-over-year declines.
Increased Customer Acquisition CostsGiven it is still early in the quarter and Teladoc’s 2Q’25 commentary on seeing an increase in customer acquisition costs, caution remains on the near-term trajectory of BetterHelp.
Teladoc News
TDOC FAQ
What was Teladoc’s price range in the past 12 months?
Teladoc lowest stock price was $6.35 and its highest was $15.21 in the past 12 months.
What is Teladoc’s market cap?
Teladoc’s market cap is $1.51B.
When is Teladoc’s upcoming earnings report date?
Teladoc’s upcoming earnings report date is Oct 29, 2025 which is in 9 days.
How were Teladoc’s earnings last quarter?
Teladoc released its earnings results on Jul 29, 2025. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.258 by $0.068.
Is Teladoc overvalued?
According to Wall Street analysts Teladoc’s price is currently Undervalued.
Does Teladoc pay dividends?
Teladoc does not currently pay dividends.
What is Teladoc’s EPS estimate?
Teladoc’s EPS estimate is -0.26.
How many shares outstanding does Teladoc have?
Teladoc has 176,690,660 shares outstanding.
What happened to Teladoc’s price movement after its last earnings report?
Teladoc reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.258. Following the earnings report the stock price went down -1.726%.
Which hedge fund is a major shareholder of Teladoc?
Currently, no hedge funds are holding shares in TDOC
Teladoc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.94 (4.81% Upside)
$8.94 (4.81% Upside)
Blogger Sentiment
Bullish
TDOC Sentiment 60%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 786.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 3.5%
Last 30 Days ▼ 3.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.30%
12-Months-Change
Fundamentals
Return on Equity
-14.18%
Trailing 12-Months
Asset Growth
-17.87%
Trailing 12-Months
Company Description
Teladoc
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
TDOC Company Deck
TDOC Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Teladoc Health showed strong financial performance and progress in product innovation and international expansion. However, challenges in the BetterHelp segment and chronic care enrollment, along with increased customer acquisition costs, presented significant hurdles.View all TDOC earnings summariesTDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
TDOC Stock 12 Month Forecast
Average Price Target
$8.94
▲(4.81% Upside)
Technical Analysis
Ownership Overview
0.45% Insiders
19.80% Mutual Funds
<0.01% Other Institutional Investors
61.95% Public Companies and Individual Investors